The OCTANE study of 194 adults, presented at EASD 2026, found an average 4.1% drop over three months on oral semaglutide. Doctors call it early, unreviewed evidence.
Recap by typeshit. Full story at Healthline.
A Future Health & Medical Innovation panel weighs how much of the growing interest in peptides and exosomes is backed by evidence.
The aging doctor shares a headline saying new studies point to GLP-1 drugs slowing the biological clock, and notes himself that more research is needed.
An explainer on how GLP-1 drugs act on reward and craving in the brain, and the research testing them against alcohol, nicotine and other substance use.
Dr Alo, a cardiologist, says he is following the cardiovascular data on these drugs closely and that it is shifting how heart disease is treated.
Covers BMI eligibility, who should avoid the drugs and common side effects. Buying direct runs $149 to $299 a month for the Wegovy pill and $299 to $449 for Zepbound.
She notes the FDA approved a change to Zepbound's labeling in October 2024, adding context to a study now circulating online.
Loading…